Skip to main content
. 2017 Feb 7;12(2):e0170952. doi: 10.1371/journal.pone.0170952

Table 2. Primary and secondary study outcomes by treatment group.

Menstrual outcomes Moxibustion group, n = 75 Control group, n = 72 Unadjusted difference (95%CI) Unadjusted P-value Adjusted difference (95%CI) Adjusted P-value
Pain intensity measured by VAS
0 month 6.38±1.28 6.41±1.29 -0.04 (-0.45, 0.38) .87 -0.04 (-0.46, 0.39) .86
1 month 5.45±1.34 4.69±1.21 0.75 (0.34, 1.71) <.0001 0.75 (0.33, 1.17) <.0001
2 month 4.34±1.22 3.73±1.24 0.61 (0.21, 1.01) <.0001 0.62 (0.21, 1.03) <.0001
3 month 2.54±1.41 2.47±1.29 0.07 (-0.37, 0.51) .75 0.07 (-0.38, 0.52) .76
4 month 2.70±1.54 2.84±1.46 -0.14 (-0.63, 0.35) .57 -0.12 (-0.61, 0.38) .65
5 month 2.81±1.53 3.33±1.35 -0.51 (-0.98, -0.42) .03 -0.46 (-0.94, 0.01) .06
6 month 3.08±1.49 4.01±1.21 -0.93 (-1.38, -0.49) <.0001 -0.87 (-1.32, -0.42) <.0001
Menstrual pain duration (days)
0 month 5.38±2.79 5.63±2.88 -0.24 (-1.16, 0.69) .61 -0.34 (-1.28, 0.60) .47
1 month 1.81±1.02 1.83±1.51 -0.03 (-0.45, 0.39) .89 -0.10 (-0.52, 0.32) .65
2 month 1.52±0.98 1.61±1.67 -0.09 (-0.54, 0.35) .68 -0.14 (-0.59, 0.31) .53
3 month 1.29±1.06 1.43±1.70 -0.14 (-0.60, 0.32) .55 -0.18 (-0.65, 0.29) .44
4 month 1.05±0.92 1.18±1.52 -0.13 (-0.54, 0.28) .52 -0.17 (-0.59, 0.24) .41
5 month 1.11±0.89 1.33±1.48 -0.23 (-0.62, 0.17) .27 -0.25 (-0.66, 0.15) .22
6 month 1.23±0.89 1.63±1.47 -0.40 (-0.79, 0.00) .05 -0.43 (-0.83, -0.03) .04
Menstrual symptom intensity score measured CMSS
0 month 16.01±7.96 15.78±6.90 -0.24 (-2.20, 2.67) .85 0.26 (-2.22, 2.73) .84
1 month 14.07±7.92 12.79±6.13 1.28 (-1.04, 3.59) .28 1.28 (-1.07, 3.64) .28
2 month 10.85±6.49 10.76±6.24 0.09 (-1.99, 2.17) .93 0.03 (-2.08, 2.14) .98
3 month 6.24±4.99 7.65±5.26 -1.41 (-3.08, 0.26) .10 -1.53 (-3.23, 0.16) .08
4 month 6.12±4.95 7.71±5.25 -1.59 (-3.25, -0.07) .06 -1.66 (-3.35, -0.03) .05
5 month 5.21±4.55 8.58±5.47 -3.37 (-5.01, -1.73) <.0001 -3.45 (-5.12, -1.79) <.0001
6 month 4.84±3.19 9.78±5.38 -4.94 (-6.51, -3.37) < .0001 -4.98 (-6.58, -3.39) <.0001
Menstrual symptom duration score measured CMSS (days)
0 month 20.64±11.07 19.83±9.22 0.81 (-2.52, 4.14) .63 0.58 (-2.80, 3.96) .74
1 month 16.37±8.85 15.53±7.82 0.85 (-1.88, 3.57) .54 0.69 (-2.08, 3.46) .69
2 month 12.56±8.51 12.61±7.53 -0.05 (-2.67, 2.57) .97 -0.20 (-2.87, 2.47) .88
3 month 7.03±5.97 8.78±6.30 -1.75 (-3.75, 0.25) .09 -1.98 (-4.00, 0.05) .06
4 month 6.44±5.48 8.25±5.75 -1.81 (-3.64, 0.02) .05 -1.95 (-3.81, -0.09) .04
5 month 4.91±3.88 8.10±5.35 -3.19 (-4.71, -1.67) <.0001 -3.28 (-4.82, -1.74) <.0001
6 month 4.51±3.73 9.40±5.36 -4.89 (-6.40, -3.39) <.0001 -4.99 (-6.52, -3.47) <.0001